NEXTAGE THERAPEUTI is trading at 377.80 as of the 26th of September 2021, a -0.18 percent down since the beginning of the trading day. The stock's open price was 378.5. Equity ratings for NEXTAGE THERAPEUTI are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of June 2021 and ending today, the 26th of September 2021. Click here to learn more.
Check how we calculate scores


Nextage Therapeutics Ltd develops and commercializes in-vitro cancer diagnostic products and solutions worldwide. The company was formerly known as Micromedic Technologies Ltd and changed its name to Nextage Therapeutics Ltd in August 2020. NEXTAGE THERAPEUTI operates under Drug ManufacturersSpecialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange. more on NEXTAGE THERAPEUTI
NEXTAGE THERAPEUTI is not yet fully synchronised with the market data
The company has a current ratio of 0.43, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
NEXTAGE THERAPEUTI reported the revenue of 336 K. Net Loss for the year was (751 K) with profit before overhead, payroll, taxes, and interest of 207 K.
NEXTAGE THERAPEUTI has accumulated about 358 K in cash with (2.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16.
Roughly 91.0% of the company outstanding shares are owned by corporate insiders
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of NEXTAGE THERAPEUTI's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
NEXTAGE THERAPEUTI (NXTG) is traded on Tel Aviv Stock Exchange in Israel . The company currently falls under 'Micro-Cap' category with current market capitalization of 99.87 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NEXTAGE THERAPEUTI's market, we take the total number of its shares issued and multiply it by NEXTAGE THERAPEUTI's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. NEXTAGE THERAPEUTI operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 25.38 M outstanding shares. NEXTAGE THERAPEUTI has accumulated about 358 K in cash with (2.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16.
Check NEXTAGE THERAPEUTI Probability Of Bankruptcy

NEXTAGE Stock Against Markets

Picking the right benchmark for NEXTAGE THERAPEUTI stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in NEXTAGE THERAPEUTI stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for NEXTAGE THERAPEUTI is critical whether you are bullish or bearish towards NEXTAGE THERAPEUTI at a given time.

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NEXTAGE THERAPEUTI stock to make a market-neutral strategy. Peer analysis of NEXTAGE THERAPEUTI could also be used in its relative valuation, which is a method of valuing NEXTAGE THERAPEUTI by comparing valuation metrics with similar companies.
Additionally, see Stocks Correlation. Note that the NEXTAGE THERAPEUTI information on this page should be used as a complementary analysis to other NEXTAGE THERAPEUTI's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Tools for NEXTAGE Stock

When running NEXTAGE THERAPEUTI price analysis, check to measure NEXTAGE THERAPEUTI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NEXTAGE THERAPEUTI is operating at the current time. Most of NEXTAGE THERAPEUTI's value examination focuses on studying past and present price action to predict the probability of NEXTAGE THERAPEUTI's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move NEXTAGE THERAPEUTI's price. Additionally, you may evaluate how the addition of NEXTAGE THERAPEUTI to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios